. Overall age-and sex-adjusted incidence rates were 6 .0/100,000 and 2.5/100,000 person-years, respectively. The incidence of DCM doubled from 3.9/100,000 in the first 5 years to 7.9/100,000 person-years in the last 5 years of study. The corresponding change for HCM was from 1.4 to 3.6/100,000 person-years. Age-and sex-adjusted prevalence rates as of January 1, 1985 , for DCM and HCM were 36.5/100,000 and 19.7/100,000 population, respectively. The prevalence of DCM in persons less than 55 years old was 17.9/100,000, over a third of whom were New York Heart Association functional Class III or IV at diagnosis. These estimates may be of value in determining the potential use of health care resources, particularly cardiac transplantation.
(Circulation 1989;80:564-572) S ince the term "cardiomyopathy" was coined k 30 years ago to describe a group of myocardial diseases of unknown cause,' investigators have described many of the characteristic clinical features of the idiopathic cardiomyopathies. 2 Attempts have also been made to define their epidemiologic features, specifically the frequency of occurrence in the general population.3-10 However, with the exception of a population-based study from Malmo, Sweden,3,4 incidence and prevalence estimates have been based on data from selected population subgroups, such as patients referred to cardiac units of general hospitals or major medical institutions,6,7 cases identified at autopsy,5-7 hospital discharge and mortality statistics,9 crosssectional survey data,8 or cases identified through voluntary participation in an industrial health screening program.10 Thus, the epidemiology of the cardio-HCM FIGURE 1 . Illustration ofmethod ofdiagnosis of idiopathic dilated cardiomyopathy (DCM) and hypertrophic cardiomyopathy (HCM) among Olmsted County, Minnesota, residents, 1975 Echo, Mmode, and cross-sectional echocardiography; Angio, contrast ventriculography (all patients also had coronary angiography).
room visits, nursing home care, hospital admissions, autopsy examinations, and death certification. The 20 Patients with specific heart muscle diseases caused by known infective agents, metabolic excesses or deficiencies, sensitivity or toxic reactions, or specific heart muscle diseases associated with systemic diseases, storage diseases, or heredity or familial disorders were not included in the study. However, family members were not contacted or investigated to detect cardiac disease. Two patients with HCM and three with DCM had a documented family history possibly compatible with cardiomyopathy, but such history is likely to be incomplete.
Residency Criteria
In addition to fulfilling diagnostic criteria, patients for the incidence study must have established residence in Olmsted County for at least 1 year before diagnosis, thus excluding those who might have moved into the area for diagnosis or treatment of their cardiomyopathy. Patients for the prevalence study were required to be residing in the county on January 1, 1985, and to have had established residence in Olmsted County for at least 1 year before that date.
Data Analysis
The entire population of Olmsted County was considered to be at risk of developing idiopathic cardiomyopathy. Thus, incidence rates were calculated with the observed number of cases divided by the age-and sex-specific person-years of observation estimated from decennial census data for Olmsted County.21 Rates were also calculated separately for the city of Rochester (urban) and the balance of Olmsted County (rural). Rates were directly age-and sex-adjusted to the population structure of US whites in 1980; for comparisons between sexes, rates were age-adjusted to the same standard population. The denominator for the calculation of prevalence rates was the estimated county population on January 1, 1985. Ninety-five percent confidence intervals (95% CI) were estimated from the cumulative Poisson distribution.22 Statistical significance indicatesp less than 0.05 unless otherwise noted.
Results
During the 10-year study period, 69 Olmsted County, Minnesota, residents were diagnosed as having idiopathic cardiomyopathy. All of these individuals were white, reflecting the racial composition of the community. Of the total, 46 (67%) had dilated cardiomyopathy, and 21 (30%) had hypertrophic cardiomyopathy. One 67-year-old woman had typical hemodynamic features of restrictive cardiomyopathy, and the remaining patient's cardiomyopathy could not be classified. Sixty-six of these patients represented new diagnoses of cardiomyopathy, whereas the remaining three individuals moved to Olmsted County after the diagnosis was established and were only counted among the prevalence cases. Altogether, there were 45 patients with idiopathic cardiomyopathy residing in the community on the prevalence day of January 1, 1985.
Based on 45 new cases of DCM and 19 new cases of HCM, the age-and sex-adjusted incidence rates were 6.0/100,000 person-years (95% CI, 4.2-7.7) and 2.5/100,000 person-years (95% CI, 1.4-3.7), respectively. With a single case, the crude incidence of restrictive cardiomyopathy was estimated at 0.1/100,000 person-years. The overall age-and sex-adjusted incidence of all cardiomyopathies combined was 8.7/100,000 person-years (95% CI, 6.6-10.9) with the 66 new cases observed. There was a marked preponderance of men among the DCM and (Table 3 ). The overall age-and sexadjusted incidence of DCM increased from 3.9/ 100,000 person-years in the first 5-year period to 7.9/100,000 person-years in the second, whereas the corresponding change for HCM was from 1.4 to 3.6/100,000 person-years. Given the small numbers, incidence rates in the urban and rural areas of Olmsted County cannot be rigorously compared. Heart muscle disease of known cause; that is, that due to systemic or pulmonary hypertension, coronary artery disease, valvular or congenital heart disease, infective or metabolic causes, and those associated with systemic disorders are specifically excluded. Thus, the diagnosis of idiopathic cardiomyopathy is primarily one of exclusion supported by a combination of clinical features, many of which are nonspecific. In the absence of a specific clinical finding or diagnostic test, there are, inevitably, problems in diagnosis and classification.
A particular question arising in relation to DCM concerns the possible coexistence of coronary artery disease. Ideally, all patients with DCM should be shown to be free of coronary artery disease. In practice, however, coronary arteriography is not routinely performed in all patients with congestive heart failure. Because retrospective studies cannot control the conditions under which patients are recruited or investigated, it follows that most epidemiologic studies of DCM have had to compromise on the completeness of data on coronary artery disease in their subjects. In the Icelandic study, three fourths of the patients were shown to have normal coronary arteries;5 the proportion of the Malmo series that underwent coronary arteriography is not specified,3,4 and there are no details of coronary imaging in the United Kingdom questionnaire study.8 A previous retrospective study based on the entire Mayo Clinic practice, including referral patients, found angiographic evidence of normal coronary arteries for 58% of DCM patients.24 In this population-based study, 47% of patients were shown Echocardiographic screening of industrial workers *Overall incidence per 100,000 person-years or prevalence per 100,000 population, directly age-and sex-adjusted to the 1980 US white population.
to have normal coronary arteries or minimal atherosclerosis. However, these did include all patients who complained of angina or had electrocardiographic findings of ischemia. Moreover, the median duration of documentation in Mayo records before diagnosis was 23 years in this study, indicating that most patients were under continuous longterm medical surveillance before the diagnosis of cardiomyopathy.
A second unresolved issue in DCM is the etiologic contribution of ethanol. Several investigators have attempted to define the nature of the association between "excessive" alcohol consumption and myocardial disease,25,26 but there is still uncertainty about the degree and duration of alcohol abuse required to effect myocardial damage. There is the possibility that persons with ventricular dilatation and impaired systolic function are questioned more intensively about their drinking habits than persons with other conditions, and there is the recognized difficulty of obtaining an accurate account of alcohol intake from habitual drinkers. In this study, it would appear from entries in the medical records that 12 of the 46 DCM patients had a significant history of alcohol consumption. To have excluded these from the cohort would likely have resulted in underestimation of the incidence and prevalence of DCM. It is not clear whether or not persons with a history of alcohol abuse were excluded from other epidemiologic studies of DCM.
Other estimates of the incidence and prevalence of idiopathic dilated or hypertrophic cardiomyopathy are summarized in Table 5 . These estimates vary considerably, reflecting variation in case ascertainment and diagnostic criteria, although the possibility of some geographic variation cannot be ruled out. In Malmo, Sweden, 550 individuals with myocardial disease of diverse causes were identified from 1970 to 1979.3,4 Extensive clinical investigation established the diagnosis of DCM "firmly" in 89 patients, giving a crude annual incidence of 3.9/100,000. Another 43 persons were classified as "probably" cases, increasing the crude rate to 5.3/100,000/year, but specific criteria by which these categories were defined are not provided. The comparable group in this study (i.e., those with DCM diagnosed during life) totals 41 cases and yields a crude rate of 4.5/100,000 person-years. Although these rates appear quite similar, the Olmsted population is younger on average than that of Malmo. The Olmsted County age-and sex-specific rates applied to the Malmo population yield an adjusted incidence rate of 7/ 100,000 person-years, which can be directly compared with the Malmo rate of 5.3/100,000.
Both studies recognized additional patients in whom DCM was diagnosed at autopsy. These made up 30% of the Malmo series and 9% of the Olmsted County cohort series. This discrepancy is due to the higher proportion of elderly in the Malmo population and, more importantly, to quite different autopsy rates (90% among Malmo residents of all ages vs. about 40% of all Olmsted County deaths and 30% among older residents).27 Had all Olmsted County patients undergone autopsy, we could conceivably have found up to eight additional cases of DCM (and six more cases of HCM). Nonetheless, after the differences in age and sex distribution are accounted for by adjusting the Olmsted County rate to the Malmo population, the overall incidence rates inclusive of autopsy cases are 7.8 and 7.9/ 100,000/year, respectively, in Olmsted County and Malmo. Of interest, the population of Olmsted County is ethnically quite similar to that of Malmo, with a high proportion of residents having Northern European ancestry.
A recent report from Western Denmark noted a crude annual incidence rate of DCM of 0.7/100,000/ year.7 That study, conducted retrospectively during a 2-year period (1980) (1981) , used clinical notes from three cardiology referral centers and autopsy reports from 14 pathology departments. The low rate almost certainly reflects incomplete case ascertainment for the population under study.
To our knowledge, only one previous attempt has been made to define the prevalence of DCM. This was a questionnaire survey of family practitioners in two regions of England.8 The resulting prevalence rate of 8.3/100,000 was based on a response rate of only 54% and without objective confirmation of findings by echocardiographic or angiographic means. The overall age-and sex-adjusted prevalence of DCM in our study (36.5/100,000) is over four times that figure and seems likely to be a more accurate representation of the true prevalence.
The crude annual incidence of HCM in Western Denmark has been estimated at 0.4/100,000.7 This is in sharp contrast to the age-and sex-adjusted incidence from this study of 2.5/100,000 person-years. Even the latter figure may be an underestimate, however, because one recent report drew attention to the coexistence of HCM and hypertension, especially in the elderly,28 and patients with significant hypertension were excluded from this cohort. A study in Birmingham, England, identified 39 patients with HCM who presented to a district general hospital over a 6-year period.6 However, it is not possible to construct incidence rates from that study because of incomplete denominator data.
The reported prevalence of HCM also shows considerable variation between studies. 29 The Japanese study was confined to adult male participants in an industrial heart screening program.10 Neither of these estimates is comparable to our prevalence rate of 19.7/100,000, based predominantly on symptomatic patients coming to medical attention.
Presentation of a single incidence rate for DCM or HCM for the 10 years covered by this study may be misleading because the incidence of both conditions appears to be rising. Although this may reflect a true increase in incidence, it is more likely due to better diagnosis of the condition because of a higher index of suspicion among clinicians and increased use of echocardiography. For example, a recent study of echocardiography in the Olmsted County population revealed that use of the procedure had increased from 552/100,000 population in 1979 to 1,435/100,000 population in 1985. 30 Nonetheless, the incidence rates presented here may still be underestimates of the true rates, even for the later time period. With more thorough and definitive evaluation of cardiac symptoms and early detection of mild and asymptomatic cases, we may expect further increases in the reported incidence and prevalence of DCM and HCM. Currently, the only way to determine these rates more accurately would be to devise an ongoing screening program in the general population, which is a costly and timeconsuming venture given the relative infrequency of the condition.
The impact of the idiopathic cardiomyopathies in terms of morbidity, years of productive life lost, and health care costs is largely unknown. A recent study based on hospital discharge statistics estimated that in the United States there are about 126,000 hospital discharges annually (55/100,000 population/year) that bear a diagnosis of cardiomyopathy. 9 In 46,000 of these (20/100,000/year), cardiomyopathy is the principal diagnosis. The latter group alone accounts for 410,000 hospital-stay days. Interpretation of these data is difficult, however, because hospital statistics count discharges rather than individuals, thus taking no account of readmissions. Moreover, the diagnostic rubric used in most studies, ICD-425, includes specific as well as idiopathic forms of cardiomyopathy, and the diagnoses coded in hospital discharge data are not confirmed. This could represent a major source of error in a study of idiopathic cardiomyopathy. In the present study, for example, there were 517 individuals with diagnoses coded to ICD-425. A detailed review revealed that only 67 of the 517 (13%) could be considered bona fide cases of idiopathic cardiomyopathy. In addition, hospitalized patients represent only a fraction of all patients with cardiomyopathy. In the Olmsted County study, most patients were diagnosed and observed exclusively on an outpatient basis.
Projection of age-and sex-specific incidence and prevalence rates from the present study to 
